What is the pathophysiology of chronic obstructive pulmonary disease (COPD)?

Pathophysiology of Chronic Obstructive Pulmonary Disease (COPD)

COPD pathophysiology centers on an abnormal inflammatory immune response to inhaled noxious particles (primarily cigarette smoke) that triggers oxidative stress, protease-mediated tissue destruction, airway remodeling, and emphysematous alveolar damage, resulting in progressive airflow limitation. 1, 2

Core Pathophysiologic Mechanisms

Inflammatory Cascade and Cellular Response

The disease begins when toxic particles and gases trigger an imbalance between pro-oxidants and antioxidants (oxidative stress), which activates transcription factors and increases expression of inflammatory mediators and proteases 2. Multiple cell types orchestrate this pathologic response:

• Macrophages, epithelial cells, neutrophils, and T lymphocytes generate an oxidative and inflammatory microenvironment that drives disease progression 2
• The innate and adaptive inflammatory immune response to inhalation injury forms the foundation of COPD pathogenesis 3
• This inflammatory process is linked to a tissue-repair and remodeling process that increases mucus production and causes emphysematous destruction of gas-exchanging surfaces 3

Structural Pathology

The anatomic changes in COPD create a paradoxical pattern of simultaneous tissue destruction and thickening:

• Emphysema begins in respiratory bronchioles near thickened and narrowed small bronchioles, which become the major site of obstruction 3
• Small airways thicken in close proximity to lung tissue undergoing emphysematous destruction—a mechanism that remains incompletely understood 3
• Airway and/or alveolar abnormalities produce persistent respiratory symptoms and airflow limitation 1

Mucociliary and Airway Dysfunction

Beyond inflammation, COPD involves multiple interacting components:

• Mucociliary dysfunction, airway inflammation, and structural changes all contribute to airflow limitation 4
• Increased mucus production results from the tissue-repair process 3
• A significant systemic component extends beyond the respiratory system 4

Risk Factors and Disease Development

Primary Exposures

Cigarette smoking is the dominant risk factor, causing higher prevalence of respiratory symptoms, greater annual FEV₁ decline, and increased COPD mortality compared to nonsmokers 1. However, the pathophysiology extends beyond smoking:

• Other tobacco forms (pipe, cigar, water pipe) and marijuana are also risk factors 1
• Environmental exposures including biomass fuel and air pollution contribute to disease development 1
• Occupational exposures increase risk 1
• Passive cigarette smoke exposure contributes to respiratory symptoms and COPD 1

Host Factors and Early Life Influences

Approximately 50% of COPD cases develop from accelerated FEV₁ decline, while the other 50% result from abnormal lung growth and development 1. Key host factors include:

• Genetic abnormalities (including α₁-antitrypsin deficiency), abnormal lung development, and accelerated aging predispose individuals to COPD 1, 5
• Processes during gestation, birth, and childhood exposures affect lung growth and identify individuals at increased risk 1
• "Childhood disadvantage factors" are as important as heavy smoking in predicting adult lung function 1
• Smoking during pregnancy affects in utero lung growth and may prime the fetal immune system 1

Molecular and Epigenetic Mechanisms

Recent evidence reveals deeper pathophysiologic layers:

• Mitochondrial alterations including mitochondrial DNA damage, increased mitochondrial reactive oxygen species, abnormal autophagy, and apoptosis are implicated in COPD pathogenesis 6
• Epigenetic changes including DNA methylation, histone modification, and non-coding RNA alterations contribute to disease development 6
• Genetics and aging influence COPD development alongside environmental exposures 6

Clinical Manifestations of Pathophysiology

The structural and inflammatory changes manifest as:

• Dyspnea, cough, and/or sputum production are the most frequent symptoms, though commonly underreported 1
• Chronic respiratory symptoms may precede airflow limitation development and associate with acute respiratory events 1
• Individuals with normal spirometry can have chronic respiratory symptoms, and many smokers without airflow limitation show structural lung disease (emphysema, airway wall thickening, gas trapping) 1

Progressive Nature and Complications

COPD is characterized by:

• Acute exacerbations that punctuate the chronic disease course 1
• Significant concomitant chronic diseases that increase morbidity and mortality 1
• Progressive airflow obstruction that develops over decades 7
• Never-smokers with chronic airflow limitation have increased risk of pneumonia and mortality from respiratory failure, though without increased lung cancer or cardiovascular risk 1